Ethos Technologies Inc. LIFE

Set alert

Price alert · LIFE

All alert types
43.39 USD -0.23 -0.53%

At close · Oct 30

43.44 +0.05 +0.12%

After hours · Oct 30, 7:43 PM ET

Bid
43.36 × 2
Ask
43.40 × 2
42.15 Day range 44.33
9.85 52-week range 44.22
YTD
+157.51%
1 year
+157.51%
Open
42.20
Prev close
43.62
Mkt cap
2.82B
Vol
1.94M
Avg vol
1.57M
EPS
-2.08
P/E
0.00
Div yield
0.00%
More statistics
Low
42.15
High
44.33
Forward P/E
16.49
Beta
0.00
Short ratio
2.43
Inst. own
46.60%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
37.91
200-d avg
22.93
1y target
37.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LIFE has not been loaded yet. Try again in a moment.

Discussion (12)

Sign in to join the discussion

MrIncredible1 LIFE 5 months ago #2

$LIFE here we go back up again. Going past $35 anytime now. Time to load up!

VICKY HANUKA LIFE 2 years ago #3

Buy buy buy before it’s to late ??????????????????

VICKY HANUKA LIFE 3 years ago #4

Merge is happening October 9 don’t miss it

VICKY HANUKA LIFE 3 years ago #5

"During this quarter, we executed an agreement with United States Air Force Academy ("USAFA") for an initial amount of US$7.3million in funding from the Defense Threat Reduction Agency and USAFA for our ATI-1701 vaccine, a crucial defense against Tularemia, which is a top-priority biothreat. Our partnership with USAFA and the recent agreement execution will enable us to advance this program towards an Investigational New Drug ("IND")," said Don Cilla, Pharm.D., M.B.A., President and Chief Executive Officer of Appili Therapeutics. "Additionally, securing US patent coverage through at least 2039 for ATI-1501, our Metronidazole formulation, is a significant milestone leading up to the anticipated FDA Prescription Drug User Fee ("PDUFA") date on September 23, 2023. We look forward to receiving milestone payments and royalties from our partner, Saptalis Pharmaceuticals LLC ("Saptalis"), in the coming quarters based on their submission and commercialization plans. These achievements are expected to position us with the required resources to continue to make progress in advancing our infectious disease assets."

VICKY HANUKA LIFE 3 years ago #8

VSTM 38 cent 739% upside 3.20
Surf 68 cent 635.19 % upside 5$
Tanya 3.06$ 602.61% upside 21.50
LPTX 38 cent 583.65 upside 2.63$
LIFE 1.92 $ 837.50% upside 18$
BCEL 92cent 892.91% upside 9.10$
VERU 1.29$ 1256.59 upside 7.50$